These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 33863534)

  • 1. Differentiation between multiple sclerosis and neuromyelitis optica spectrum disorders by multiparametric quantitative MRI using convolutional neural network.
    Hagiwara A; Otsuka Y; Andica C; Kato S; Yokoyama K; Hori M; Fujita S; Kamagata K; Hattori N; Aoki S
    J Clin Neurosci; 2021 May; 87():55-58. PubMed ID: 33863534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation between multiple sclerosis and neuromyelitis optica spectrum disorder using a deep learning model.
    Seok JM; Cho W; Chung YH; Ju H; Kim ST; Seong JK; Min JH
    Sci Rep; 2023 Jul; 13(1):11625. PubMed ID: 37468553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging Differences between Neuromyelitis Optica Spectrum Disorders and Multiple Sclerosis: A Multi-Institutional Study in Japan.
    Tatekawa H; Sakamoto S; Hori M; Kaichi Y; Kunimatsu A; Akazawa K; Miyasaka T; Oba H; Okubo T; Hasuo K; Yamada K; Taoka T; Doishita S; Shimono T; Miki Y
    AJNR Am J Neuroradiol; 2018 Jul; 39(7):1239-1247. PubMed ID: 29724765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain and spinal cord lesion criteria distinguishes AQP4-positive neuromyelitis optica and MOG-positive disease from multiple sclerosis.
    Bensi C; Marrodan M; González A; Chertcoff A; Osa Sanz E; Chaves H; Schteinschnaider A; Correale J; Farez MF
    Mult Scler Relat Disord; 2018 Oct; 25():246-250. PubMed ID: 30144694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain and cord imaging features in neuromyelitis optica spectrum disorders.
    Cacciaguerra L; Meani A; Mesaros S; Radaelli M; Palace J; Dujmovic-Basuroski I; Pagani E; Martinelli V; Matthews L; Drulovic J; Leite MI; Comi G; Filippi M; Rocca MA
    Ann Neurol; 2019 Mar; 85(3):371-384. PubMed ID: 30635936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiate aquaporin-4 antibody negative neuromyelitis optica spectrum disorders from multiple sclerosis by multimodal advanced MRI techniques.
    Zhang N; Sun J; Wang Q; Qin W; Zhang X; Qi Y; Yang L; Shi FD; Yu C
    Mult Scler Relat Disord; 2020 Jun; 41():102035. PubMed ID: 32200338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of cerebral damage in multiple sclerosis and aquaporin-4 antibody-positive neuromyelitis optica spectrum disorders-major differences revealed by non-conventional imaging.
    Jakuszyk P; Podlecka-Piętowska A; Kossowski B; Nojszewska M; Zakrzewska-Pniewska B; Juryńczyk M
    Brain Commun; 2024; 6(5):fcae295. PubMed ID: 39258257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuromyelitis optica spectrum disorder mimicking multiple sclerosis.
    van Rooij LC; Wattjes MP; de Jong BA; van Oosten BW
    Mult Scler Relat Disord; 2017 Oct; 17():54-56. PubMed ID: 29055475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRI-Based Methods for Spinal Cord Atrophy Evaluation: A Comparison of Cervical Cord Cross-Sectional Area, Cervical Cord Volume, and Full Spinal Cord Volume in Patients with Aquaporin-4 Antibody Seropositive Neuromyelitis Optica Spectrum Disorders.
    Chien C; Brandt AU; Schmidt F; Bellmann-Strobl J; Ruprecht K; Paul F; Scheel M
    AJNR Am J Neuroradiol; 2018 Jul; 39(7):1362-1368. PubMed ID: 29748202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuromyelitis optica spectrum disorder and multiple sclerosis: Differentiation by a multimodal approach.
    Ota M; Sato N; Okamoto T; Noda T; Araki M; Yamamura T; Kunugi H
    Mult Scler Relat Disord; 2015 Nov; 4(6):515-20. PubMed ID: 26590657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain magnetic resonance imaging features in multiple sclerosis and neuromyelitis optica spectrum disorders patients with or without aquaporin-4 antibody in a Latin American population.
    Silveira F; Pappolla A; Sánchez F; Marques VD; de Castillo IS; Tkachuk V; Caride A; Castillo MC; Cristiano E; Cruz CA; Diégues Serva GB; Dos Santos AC; Moreira CL; López PA; Patrucco L; Molina O; Pettinicchi JP; Carnero Contentti E; Rojas JI
    Mult Scler Relat Disord; 2020 Jul; 42():102049. PubMed ID: 32251869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron and Non-Iron-Related Characteristics of Multiple Sclerosis and Neuromyelitis Optica Lesions at 7T MRI.
    Chawla S; Kister I; Wuerfel J; Brisset JC; Liu S; Sinnecker T; Dusek P; Haacke EM; Paul F; Ge Y
    AJNR Am J Neuroradiol; 2016 Jul; 37(7):1223-30. PubMed ID: 27012298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transformer-Based Deep-Learning Algorithm for Discriminating Demyelinating Diseases of the Central Nervous System With Neuroimaging.
    Huang C; Chen W; Liu B; Yu R; Chen X; Tang F; Liu J; Lu W
    Front Immunol; 2022; 13():897959. PubMed ID: 35774780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential brainstem atrophy patterns in multiple sclerosis and neuromyelitis optica spectrum disorders.
    Lee CY; Mak HK; Chiu PW; Chang HC; Barkhof F; Chan KH
    J Magn Reson Imaging; 2018 Jun; 47(6):1601-1609. PubMed ID: 28990252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantifying visual pathway axonal and myelin loss in multiple sclerosis and neuromyelitis optica.
    Manogaran P; Vavasour IM; Lange AP; Zhao Y; McMullen K; Rauscher A; Carruthers R; Li DKB; Traboulsee AL; Kolind SH
    Neuroimage Clin; 2016; 11():743-750. PubMed ID: 27330974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct brain imaging characteristics of autoantibody-mediated CNS conditions and multiple sclerosis.
    Jurynczyk M; Geraldes R; Probert F; Woodhall MR; Waters P; Tackley G; DeLuca G; Chandratre S; Leite MI; Vincent A; Palace J
    Brain; 2017 Mar; 140(3):617-627. PubMed ID: 28364548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative radiomic biomarkers for discrimination between neuromyelitis optica spectrum disorder and multiple sclerosis.
    Ma X; Zhang L; Huang D; Lyu J; Fang M; Hu J; Zang Y; Zhang D; Shao H; Ma L; Tian J; Dong D; Lou X
    J Magn Reson Imaging; 2019 Apr; 49(4):1113-1121. PubMed ID: 30408268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. χ-Separation Imaging for Diagnosis of Multiple Sclerosis versus Neuromyelitis Optica Spectrum Disorder.
    Kim W; Shin HG; Lee H; Park D; Kang J; Nam Y; Lee J; Jang J
    Radiology; 2023 Apr; 307(1):e220941. PubMed ID: 36413128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Classification algorithms with multi-modal data fusion could accurately distinguish neuromyelitis optica from multiple sclerosis.
    Eshaghi A; Riyahi-Alam S; Saeedi R; Roostaei T; Nazeri A; Aghsaei A; Doosti R; Ganjgahi H; Bodini B; Shakourirad A; Pakravan M; Ghana'ati H; Firouznia K; Zarei M; Azimi AR; Sahraian MA
    Neuroimage Clin; 2015; 7():306-14. PubMed ID: 25610795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spinal cord involvement by atrophy and associations with disability are different between multiple sclerosis and neuromyelitis optica spectrum disorder.
    Nakamura Y; Liu Z; Fukumoto S; Shinoda K; Sakoda A; Matsushita T; Hayashida S; Isobe N; Watanabe M; Hiwatashi A; Yamasaki R; Kira JI
    Eur J Neurol; 2020 Jan; 27(1):92-99. PubMed ID: 31304648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.